Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...
Chinese AI company MiniMax has released the weights for MiniMax M2.7, a 229-billion-parameter Mixture-of-Experts model that participated in its own development cycle – marking what the company calls ...
In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
XDA Developers on MSN
I tested Claude's two biggest competitors because of its usage limits, and one banned my account
I don't really know why, though.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results